Chipman Robert Geoffrey Stroud

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Chipman Robert Geoffrey Stroud is active.

Explore More

Publication

Featured researches published by Chipman Robert Geoffrey Stroud.

Acta Oncologica | 2017

Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database

Abdul Rafeh Naqash; Chipman Robert Geoffrey Stroud; Muhammad Butt; Grace K. Dy; Aparna Madhukeshwar Hegde; Mahvish Muzaffar; Li V. Yang; Maida Hafiz; Cynthia R. Cherry; Paul R. Walker

Abdul Rafeh Naqash , Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, Grace K. Dy, Aparna Hegde, Mahvish Muzaffar, Li V. Yang, Maida Hafiz, Cynthia R. Cherry and Paul R. Walker Division of Hematology/Oncology, East Carolina University, Greenville, NC, USA; Division of Cardiovascular Research, University of Kentucky Medical Center, Lexington, KY, USA; Department of Thoracic Oncology, Roswell Park Cancer Center, Buffalo, NY, USA; Department of Internal Medicine, East Carolina University, Greenville, NC, USA; Department of Thoracic Oncology, East Carolina University, Greenville, NC, USA

Journal of Clinical Oncology | 2017

Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer.

Ramya Pinnamaneni; Aparna Madhukeshwar Hegde; Sulochana Devi Cherukuri; Hyder Husain Arastu; Mark R. Bowling; Clinton Leinweber; Chipman Robert Geoffrey Stroud; Cynthia R. Cherry; Paul R. Walker

Journal of Thoracic Oncology | 2017

4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy: Topic: Medical Oncology

Abdul Rafeh Naqash; Chipman Robert Geoffrey Stroud; Cynthia R. Cherry; Mahvish Muzaffar; Mark R. Bowling; Paul R. Walker

Journal of Thoracic Oncology | 2017

OA03.05 Tocilizumab for the Management of Immune Mediated Adverse Events Secondary to PD-1 Blockade: Overall Survival Analysis: Topic: Medical Oncology

Chipman Robert Geoffrey Stroud; Aparna Madhukeshwar Hegde; Abdul Rafeh Naqash; Cynthia R. Cherry; Teresa Parent; Jessica Hardin; Paul R. Walker

Journal of Clinical Oncology | 2016

Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors.

Nitika Sharma; Chipman Robert Geoffrey Stroud; Paul R. Walker; Cynthia R. Cherry; Sulochana Devi Cherukuri; Srikala Addepalli; Teresa Parent; Jessica Hardin

Journal of Clinical Oncology | 2018

Survival stratification using a baseline inflammatory physiology based scoring system in advanced non-small cell lung cancer (NSCLC) treated with anti-programmed cell death-1 (anti-PD-1) therapy.

Abdul Rafeh Naqash; Chipman Robert Geoffrey Stroud; Mahvish Muzaffar; Li V. Yang; Paul R. Walker

Journal of Clinical Oncology | 2018

Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases.

Srikala Addepalli; Chipman Robert Geoffrey Stroud; Sulochana Devi Cherukuri; Cynthia R. Cherry; Nitika Sharma; Teresa Parent; Jessica Hardin; Paul R. Walker

Cancer Research | 2018